Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Key Milestones in the Molecular Diagnostics Devices And Equipment Market’s Growth Trajectory From 2025 To 2034?
The market for molecular diagnostics devices and equipment has witnessed a swift expansion in recent years. The market size, which stood at $24.4 billion in 2024, is projected to climb to $27.23 billion in 2025, with a compound annual growth rate (CAGR) of 11.6%. Factors contributing to the growth experienced in the historic period include enhanced funding, escalated healthcare spending, economic progression in emerging markets, quick technological developments, the emergence of new pathogenic infestations, and a rapidly rising elderly population.
The market size for molecular diagnostics devices and equipment is predicted to undergo swift expansion in the coming years, escalating to $42.59 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 11.8%. The forecast period’s growth can be tied to the quick proliferation of several bacterial and viral epidemics, an aging population, expanded healthcare accessibility, a surge in chronic diseases prevalence, and a heightened need for molecular diagnostic devices and equipment due to COVID-19. Major trends during the forecast period encompass automation in molecular diagnostics, the implementation of artificial intelligence, amplified need for molecular diagnostic devices for studying rare diseases, burgeoning adoption of big data, utilization of next-generation sequencing for newborn screening, and incorporation of point-of-care molecular diagnostics (POC mdx).
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2595&type=smp
What Are the Primary Drivers Supporting the Market Growth of the Molecular Diagnostics Devices And Equipment Market?
The increase in infectious diseases is anticipated to fuel the expansion of the molecular diagnostic devices and equipment market in the future. Illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread from one person to another or from animals to humans constitute infectious diseases. The increase in infectious diseases is driven by factors like resistance to antimicrobial agents, globalization and travel, urban development, socioeconomic inequalities, and an aging population. Molecular diagnostic tools and equipment play a crucial role in identifying and controlling infectious diseases. For example, in March 2023, the Office for National Statistics, a governmental department in the UK, reported that in the week ending March 17, 2023, the UK noted 619 COVID-19-related fatalities, a rise from 605 the previous week. During that week, COVID-19 deaths accounted for 4.5% of all deaths in the UK, slightly lower than the previous week’s 4.6%. As such, the increasing prevalence of infectious diseases is propelling the growth of the molecular diagnostic devices and equipment market.
Which Primary Segments of the Molecular Diagnostics Devices And Equipment Market Are Driving Growth and Industry Transformations?
The molecular diagnostics devices and equipmentmarket covered in this report is segmented –
1) By Product: Instruments, Reagents And Consumables, Software
2) By Technology: DNA(Deoxyribonucleic acid) sequencing, Polymerase chain reaction, Isothermal Nucleic Acid Amplification Technology, Transcription Mediated Amplification (TMA), In situ hybridization, Microarrays, Mass spectrometry, Other Technologies
3) By Application: Cancer, Pharmacogenomics, Genetic testing, Infectious disease, Prenatal, Other Applications
4) By End User: Diagnostic laboratories, Hospitals, Other End Users
Subsegments:
1) By Instruments: Polymerase Chain Reaction (PCR) Machines, Nucleic Acid Analyzers, DNA Sequencers, Microarrays
2) By Reagents And Consumables: PCR Reagents, DNA Probes And Primers, Sample Preparation Kits, Control And Calibration Materials
3) By Software: Data Analysis Software, Laboratory Information Management Systems (LIMS), Bioinformatics Software, Integration Software For Instrumentation
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=2595&type=smp
Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Molecular Diagnostics Devices And Equipment Market?# Market?
Asia-Pacific was the largest region in the global molecular diagnostics devices (or) equipment market in 2024. Western Europe was the second largest market in molecular diagnostics devices (or) equipment market. The regions covered in the molecular diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Most Significant Market Trends in the Molecular Diagnostics Devices And Equipment Market?
Prominent companies in the molecular diagnostic market are investing in the development of automated solutions for devices and tools used in molecular diagnostic procedures. The automation is aimed to boost the productivity and uniformity of the entire diagnostic procedure. Shifting to digital diagnostics offers reliable and proficient test results which are not often achieved with manual testing. Leading companies in the sector are adopting the use of nanotechnology-based Oral Fluid Nano Sensor Test (OFNASET). This test leverages a microfluidic-based nanosensor to identify oral cancer biomarkers in saliva. In response to the automation and precision trend, Roche developed cobas connection modules (CCM) to enhance scalability and the efficiency of sample-flow, enabling samples to seamlessly transition between various systems and devices. This has led to the creation of a fully automated workflow.
View the full report here:
What Parameters Are Used to Define the Molecular Diagnostics Devices And Equipment Market?
Molecular diagnostics devices are used to diagnose infectious diseases and perform screening by detecting specific sequences in DNA or RNA. It helps doctors prescribe more accurate therapeutic interventions in the early stages of a disease.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2595
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model